Author reply

R. J. Commons, R. Hannah, B. J. Currie

Research output: Contribution to journal › Letter › Research

Abstract

[No abstract available]
Original languageEnglish
Pages (from-to)591-591
Number of pages1
JournalInternal Medicine Journal
Volume45
Issue number5
DOIs
Publication statusPublished - May 2015

Cite this

Commons, R. J. ; Hannah, R. ; Currie, B. J. / Author reply. In: Internal Medicine Journal. 2015 ; Vol. 45, No. 5. pp. 591-591.
@article{41fa74eed02e410aa25d76b1f237ca77,
title = "Author reply",
abstract = "[No abstract available]",
keywords = "adalimumab, ceftazidime, corticosteroid, interleukin 12, natalizumab, rain, tumor necrosis factor alpha, amoxicillin plus clavulanic acid, antiinfective agent, antirheumatic agent, monoclonal antibody, ankylosing spondylitis, antibiotic therapy, bacteremia, biological therapy, blood culture, Burkholderia pseudomallei, chronic lung disease, corticosteroid therapy, disease association, disease predisposition, drug megadose, fever, gardening, headache, host resistance, human, immunosuppressive treatment, immunotherapy, inoculation, lethargy, Letter, melioidosis, nausea, nonhuman, postmarketing surveillance, priority journal, progressive multifocal leukoencephalopathy, psoriasis, risk factor, Arthritis, Psoriatic, male, Amoxicillin-Potassium Clavulanate Combination, Anti-Infective Agents, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Humans, Male, Melioidosis",
author = "Commons, {R. J.} and R. Hannah and Currie, {B. J.}",
year = "2015",
month = "5",
doi = "10.1111/imj.12744",
language = "English",
volume = "45",
pages = "591--591",
journal = "Internal Medicine Journal",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "5",

}

Commons, RJ, Hannah, R & Currie, BJ 2015, 'Author reply', Internal Medicine Journal, vol. 45, no. 5, pp. 591-591. https://doi.org/10.1111/imj.12744

Author reply. / Commons, R. J.; Hannah, R.; Currie, B. J.

In: Internal Medicine Journal, Vol. 45, No. 5, 05.2015, p. 591-591.

Research output: Contribution to journal › Letter › Research

TY - JOUR

T1 - Author reply

AU - Commons, R. J.

AU - Hannah, R.

AU - Currie, B. J.

PY - 2015/5

Y1 - 2015/5

N2 - [No abstract available]

AB - [No abstract available]

KW - adalimumab

KW - ceftazidime

KW - corticosteroid

KW - interleukin 12

KW - natalizumab

KW - rain

KW - tumor necrosis factor alpha

KW - amoxicillin plus clavulanic acid

KW - antiinfective agent

KW - antirheumatic agent

KW - monoclonal antibody

KW - ankylosing spondylitis

KW - antibiotic therapy

KW - bacteremia

KW - biological therapy

KW - blood culture

KW - Burkholderia pseudomallei

KW - chronic lung disease

KW - corticosteroid therapy

KW - disease association

KW - disease predisposition

KW - drug megadose

KW - fever

KW - gardening

KW - headache

KW - host resistance

KW - human

KW - immunosuppressive treatment

KW - immunotherapy

KW - inoculation

KW - lethargy

KW - Letter

KW - melioidosis

KW - nausea

KW - nonhuman

KW - postmarketing surveillance

KW - priority journal

KW - progressive multifocal leukoencephalopathy

KW - psoriasis

KW - risk factor

KW - Arthritis, Psoriatic

KW - male

KW - Amoxicillin-Potassium Clavulanate Combination

KW - Anti-Infective Agents

KW - Antibodies, Monoclonal, Humanized

KW - Antirheumatic Agents

KW - Humans

KW - Male

KW - Melioidosis

UR - http://www.scopus.com/inward/record.url?scp=84928988994&partnerID=8YFLogxK

U2 - 10.1111/imj.12744

DO - 10.1111/imj.12744

M3 - Letter

VL - 45

SP - 591

EP - 591

JO - Internal Medicine Journal

JF - Internal Medicine Journal

SN - 1444-0903

IS - 5

ER -

Commons RJ, Hannah R, Currie BJ. Author reply. Internal Medicine Journal. 2015 May;45(5):591-591. https://doi.org/10.1111/imj.12744

Access to Document